BERLIN — The health of a cancer patient’s thymus could be linked to survival outcomes with immunotherapy, regardless of the tumor type and independent of established tumor-based biomarkers, suggests ...
In cancer patients, the health of the thymus—a key part of the body's immune system—is associated with the outcomes these patients experience after immune checkpoint inhibitor treatment, according to ...
The health of the thymus - a key part of the body's immune system - is associated with cancer patients' outcomes to immune checkpoint inhibitor treatment, according to a ground-breaking international ...
Lugano/Berlin, 16 October 2025 - The health of the thymus – a key part of the body’s immune system - is associated with cancer patients’ outcomes to immune checkpoint inhibitor treatment, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback